In today's article we are going to explore Günter Ollenschläger, a highly relevant topic that has captured the attention of many people in recent times. With a detailed and exhaustive approach, we will dive into the most important and controversial aspects related to Günter Ollenschläger, with the aim of offering a complete and objective view on the topic. Through research and in-depth analysis, we will examine the implications and repercussions that Günter Ollenschläger has in different areas of society, as well as possible solutions or approaches to address this issue effectively. Don't miss this opportunity to deepen your knowledge about Günter Ollenschläger and gain a broader and more informed perspective on this highly relevant issue.
Günter Ollenschläger (born 3 March 1951 in Bonn) is a German physician, medical editor, and á former professor of internal medicine and clinical decision making at the University of Cologne, Faculty of Medicine.
Günter Ollenschläger worked as a research pharmacist from 1975 until 1981, and as a university physician from 1983 until 1990, working in the fields of pharmacokinetics, tumor related malnutrition, and metabolism.
Ollenschläger joined the German Medical Association as director of Continuing Medical Education from 1990 until 1995. From 1995 until 2014 he was founding head of the German Agency for Quality in Medicine. In that capacity he introduced a variety of projects to develop evidence based healthcare and knowledge management as well as patient safety in German healthcare:
^Ollenschläger G, Thomas W, Konkol K, Diehl V, Roth E: Nutritional behaviour and quality of life during oncological polychemotherapy: Results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukemia. Eur J Clin Invest 1992; 22: 546-553
^Sänger, S; Nickel, J; Huth, A; Ollenschläger, G (2002). "Gut informiert über Gesundheitsfragen, aber wie? - Das Deutsche Clearingverfahren für Patienteninformationen - Zielsetzung, Hintergrund und Arbeitsweise" [Well-informed on health matters--how well? The German 'Clearinghouse for Patient Information'--objective, background and methods]. Das Gesundheitswesen (in German). 64 (7): 391–7. doi:10.1055/s-2002-32812. PMID12119584. S2CID116193075.
^Ollenschläger, Günter; Kopp, Ina (2007). "Nationale VersorgungsLeitlinien von BÄK, AWMF und KBV" [The German program for disease management guidelines. Results and perspectives]. Medizinische Klinik (in German). 102 (5): 383–7. doi:10.1007/s00063-007-1052-1. PMID17497089. S2CID31255706.
^Weinbrenner, Susanne; Conrad, Susann; Weikert, Beate; Kopp, Ina (2010). "7 Jahre Nationale VersorgungsLeitlinien (NVL) - Quo vadis?" [After seven years of National Disease Management Guidelines: quo vadis?]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (in German). 104 (7): 533–9. doi:10.1016/j.zefq.2010.07.010. PMID21095605.
^Schaefer, Corinna; Kirschning, Silke (2010). "Gut informiert entscheiden: Patienten- und Verbraucherinformationen am ÄZQ" [Informed decisions: patient and consumer information at the German Agency for Quality in Medicine (ÄZQ)]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (in German). 104 (7): 578–84. doi:10.1016/j.zefq.2010.09.001. PMID21095611.
^Ollenschläger, G. (2001), "Medizinische Risiken, Fehler und Patientensicherheit. Zur Situation in Deutschland", Schweizerische Ärztezeitung (in German), 82 (26): 1404–10, doi:10.4414/saez.2001.08273
^DNEbM Office. History of the German Network for Evidence-based Medicine,Berlin 2007
^G. Ollenschläger, C. Marshall, S. Qureshi et al.: Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care 2004;13:455-460